Incidence and Risk Factors of Retinopathy of Prematurity (ROP) – A Prospective Study in a Tertiary Care Centre-Patna

Ravi Jha 1 * , Hima Charan 1, Kumar Vivek 2
More Detail
1 Departent of Paediatrics, Kurji Holy Family Hospital, Patna, Bihar, India.
2 Departent of Ophthalmology, Kurji Holy Family Hospital, Patna, Bihar, India.
* Corresponding Author
J CLIN MED KAZ, Volume 23, Issue 1, pp. 7-16. https://doi.org/10.23950/jcmk/17724
OPEN ACCESS 277 Views 58 Downloads
Download Full Text (PDF)
Author Contributions: Conceptualization, R.J. and H.C.; experimentation, R.J.; analysis, R.J., H.C. and K.V.; data curation, R.J.; imaging, R.J.; writing original draft, R.J. and K.V.; review and editing, R.J., H.C. and K.V.; supervision, R.J. and K.V.; review and editing, H.C. and K.V. All authors have read and agreed to the published version of the manuscript.

Data availability statement: All raw data underlying the findings of this study can be obtained from the corresponding author upon reasonable request.

Artificial Intelligence (AI) Disclosure Statement: AI-Unassisted Work.

ABSTRACT

Aim: Retinopathy Of Prematurity is a complex disease of developing retinal vasculature that primarily affects one or both eyes of premature babies. There are certain risk factors for ROP like RDS, CPAP, Mechanical Ventilation, Prolonged oxygen supplementation and few others. Screening of high-risk neonates at the right time will lead to early diagnosis and treatment thus preventing blindness due to ROP.
Methods: After getting approval from ethical committee, this study was carried out from 1-9-2019 to 31-8-2020. It included 177 neonates based on inclusion criteria. Babies were screened by ophthalmologist trained in ROP screening. Pupils were dilated using 0.5% Tropicamide+2.5% Phenylephrine eye drops till dilation was obtained. To study the incidence of ROP and associated risk factors of ROP in, (a)Preterm with gestational age of ≤ 34 weeks and/or birth weight < 1750 gm. (b) Selected preterm with birth weight 1751-2000gm and/or 34-36 weeks who are at high risk due to associated risk factors.
Results: The present study observed the incidence of ROP as 29.94%. On univariate analysis, Prematurity (P<0.001), Low Birth Weight (P<0.001), Supplemental Oxygen (P<0.001), respiratory distress syndrome (RDS), Apnea of Prematurity (AOP) (P<0.001), Blood transfusion (P<0.001), Sepsis (P<0.001), Feed Intolerance (P<0.001), Phototherapy (P<0.001), and Singleton Pregnancy (P<0.01) have risk factors for ROP.
Conclusion:  Reducing the incidence of ROP may be achievable through the prevention of prematurity, careful management of at-risk infants, and minimization of contributing risk factors. Effective screening and timely intervention will prevent the progression of ROP to end stages thus decreasing the incidence of Blindness.
Keywords: Retinopathy of prematurity, blindness, premature babies, pupils.

CITATION

Jha R, Charan H, Vivek K. Incidence and Risk Factors of Retinopathy of Prematurity (ROP) – A Prospective Study in a Tertiary Care Centre-Patna. J CLIN MED KAZ. 2026;23(1):7-16. https://doi.org/10.23950/jcmk/17724

REFERENCES

  • National Health Portal (Gateway of authentic health information Disease –Retinopathy of prematurity). www.nhp.gov.in.
  • Nelson-3rd vol., Disorders of the retina and vitreous. 2016: 3049.
  • IAP protocol in neonatology. 2016: 262.
  • Cloherty and Stark’s manual of neonatal care 8th edition, p. 987.
  • Chaudhari S, Patwardhan V, Vaidya U, Kadam S, Kamat A. Retinopathy of prematurity in a tertiary care center--incidence, risk factors and outcome. Indian Pediatr. 2009;46(3):219-224.
  • Shetty SP, Shetty J, Amin H, Shenoy RD. The incidence, risk factors and outcome of retinopathy of prematurity at a tertiary care centre in south India. J Dent Med Sci. 2015;14:77-83.
  • Singh M. Miscellaneous conditions: retinopathy of prematurity. In Care of the Newborn 2010 (pp. 425-428). Sagar Publications, New Delhi.
  • Gilbert C, Foster A. Childhood blindness in the context of VISION 2020: the right to sight. Bulletin of the World Health Organization. 2001;79(3):227-232.
  • AIIMS protocols in Neonatology 2018 reprint edition p. 268.
  • Kumar P, Sankar MJ, Deorari A, Azad R, Chandra P, Agarwal R, Paul V. Risk factors for severe retinopathy of prematurity in preterm low birth weight neonates. The Indian Journal of Pediatrics. 2011;78:812-816.
  • Aggarwal R, Deorari AK, Azad RV, Kumar H, Talwar D, Sethi A, Paula VK. Changing profile of retinopathy of prematurity. Journal of tropical pediatrics. 2002;48(4):239-242.
  • Bashinsky AL: Retinopathy of prematurity. N C Med J. 2017;78:124-128. https://doi.org/10.18043/ncm.78.2.124
  • Azami M, Jaafari Z, Rahmati S, Farahani AD, Badfar G: Prevalence and risk factors of retinopathy of prematurity in Iran: a systematic review and meta-analysis. BMC Ophthalmol. 2018;18:83. https://doi.org/10.1186/s12886-018-0732-3
  • Zarei M, Bazvand F, Ebrahimiadib N, et al.: Prevalence and risk factors of retinopathy of prematurity in Iran. J Ophthalmic Vis Res. 2019; 14: 291-298. https://doi.org/10.18502/jovr.v14i3.4785
  • Onyango O, Sitati S, Amolo L, et al.: Retinopathy of prematurity in Kenya: prevalence and risk factors in a hospital with advanced neonatal care. Pan Afr Med J. 2018; 29:152. https://doi.org/10.11604/pamj.2018.29.152.14046
  • Wang D, Duke R, Chan RP, Campbell JP: Retinopathy of prematurity in Africa: a systematic review. Ophthalmic Epidemiol. 2019;26:223-230. https://doi.org/10.1080/09286586.2019.1585885
  • Adio AO, Ugwu RO, Nwokocha CG, Eneh AU: Retinopathy of prematurity in port harcourt, Nigeria. ISRN Ophthalmol. 2014;2014:481527. https://doi.org/10.1155/2014/481527
  • Norman M, Hellström A, Hallberg B, et al. Prevalence of severe visual disability among preterm children with retinopathy of prematurity and association with adherence to best practice guidelines. JAMA Netw Open. 2019;2(14):e186801 https://doi.org/10.1001/jamanetworkopen.2018.6801
  • Hellström A, Smith LE, Dammann O: Retinopathy of prematurity. Lancet. 2013; 382:1445-1457. https://doi.org/10.1016/S0140-6736(13)60178-6
  • Bowe T, Nyamai L, Ademola-Popoola D, et al.: The current state of retinopathy of prematurity in India, Kenya, Mexico, Nigeria, Philippines, Romania, Thailand, and Venezuela. Digit J Ophthalmol. 2019;25:49-58. https://doi.org/10.5693/djo.01.2019.08.002
  • Edy Siswanto J, Sauer PJ: Retinopathy of prematurity in Indonesia: incidence and risk factors. J Neonatal Perinatal Med. 2017;10:85-90. https://doi.org/10.3233/NPM-915142
  • Braimah IZ, Enweronu-Laryea C, Sackey AH, et al.: Incidence and risk factors of retinopathy of prematurity in Korle-Bu Teaching Hospital: a baseline prospective study. BMJ Open. 2020;10:e035341. https://doi.org/10.1136/bmjopen-2019-035341
  • AlBalawi HB, AlBalawi NS, AlSuhaimi NA, et al.: Incidence and risk factors for retinopathy of prematurity in Tabuk City, KSA. Middle East Afr J Ophthalmol. 2020;27:105-109. https://doi.org/10.4103/meajo.MEAJO_195_19
  • Chyne JK, Lim CT, Leong HL, Wong PK. Retinopathy of Prematurity in very low birthweight infants. Ann Acad Med Singapore. 1999;28(2):193-198.
  • Hedelius HC, Dahl H. Retinopathy of prematurity, a decrease in frequency and severity. Acta Opthalmol scand. 2000;78:359-361.
  • Bayat-Mokhtari M, Pishva N, Attarzadeh A, Hosseini H, Pourarian S. Incidence and risk factors of retinopathy of prematurity among preterm infants in Shiraz/Iran. Iranian journal of pediatrics. 2010;20(3):303.
  • Bassiouny R; Ellakkany RS; Aboelkhair SA; Mohsen TA; Othman IS. incidence and risk factors of retinopathy of prematurity in neonatal intensive care units: Mansoura, Egypt. Journal of the Egyptian Ophthalmological Society. 2017;110 (3):71-76. https://doi.org/10.4103/ejos.ejos_25_17
  • Freilas AM, Morschbacher R. Thorell MR, Rhoden EL. incidence and risk factors for retinopathy of prematurity; a retrospective cohort study. Int J Retin Vitr. 2018; 20(4). https://doi.org/10.1186/s40942-018-0125-z
  • Bas AY, Demirel N, Koc E, Isik DU, Hirfanoglu IM, Tunc T. Incidence, risk factors and severity of retinopathy of prematurity in Turkey (TR-ROP study): a prospective, multicentre study in 69 neonatal intensive care units. British Journal of Ophthalmology. 2018;102:1711-1716. https://doi.org/10.1136/bjophthalmol-2017-311789
  • Khorshidifar M, Nikkhah H, Ramezani A, Entezari M, Daftarian N, Norouzi H, Shahiari M, Radfar M, Norinia R, Karimi S. Incidence and risk factors of retinopathy of prematurity and utility of the national screening criteria in a tertiary center in Iran. International journal of ophthalmology. 2019;12(8):1330.
  • Martin RJ, Fanaroff AA, Walsh MC. Fanaroff and Martin's neonatal-perinatal medicine e-book: diseases of the fetus and infant. Elsevier Health Sciences; 2014 Aug 20.
  • Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. One-year outcome-structure and function. Arch Ophthalmol. 1990;108:1408-16.
  • Fortes Filho JB, Barros CK, Costa MC, Procianoy RS. Results of a program for the prevention of blindness caused by retinopathy of prematurity in southern Brazil. Jornal de Pediatria. 2007;83:209-216.
  • International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Archives of Ophthalmology (Chicago, Ill.: 1960). 2005;123(7):991-999.
  • Mutlu FM, Sarici SU. Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options. International Journal of Ophthalmology. 2013;6(2):228.
  • Johnson L, Schaffer D, Boggs TR. The premature infant, vitamin E deficiency and retce: rolental fibroplasia12. The American Journal of Clinical Nutrition. 1974;27(10):1158-1173.
  • Quinn GE, Johnson L, Abbasi S. Onset of retinopathy of prematurity as related to postnatal and postconceptional age. British journal of ophthalmology. 1992;76(5):284-288.
  • Johnson L, Quinn GE, Abbasi S, Otis C, Goldstein D, Sacks L, Porat R, Fong E, Delivoria-Papadopoulos M, Peckham G, Schaffer DB. Effect of sustained pharmacologic vitamin E levels on incidence and severity of retinopathy of prematurity: a controlled clinical trial. The Journal of pediatrics. 1989;114(5):827-838.
  • Singh A. Guidelines for Universal eye Screening in Newborns Including Retinopathy of Prematurity: Rashtriya Bal Swasthya Karyakram. Ministry of Health and Family Welfare, Government of India. 2017.
  • Charan R, Dogra MR, Gupta A, Narang A. The incidence of retinopathy of prematurity in a neonatal care unit. Indian journal of ophthalmology. 1995;43(3):123-126.
  • Nikhil R, Rajendran K, Krishnan B. Prevalence and outcome of retinopathy of prematurity in preterm infants, with low birth weight at KMCH, Tamil Nadu, India. International Journal of Contemporary Pediatrics. 2019; 6(2): 264–268. https://doi.org/10.18203/2349-3291.ijcp20185519
  • Patel SS, Shendurnikar N. Retinopathy of prematurity in India: incidence, risk factors, outcome and the applicability of current screening criteria. Int J Contemp Pediatr. 2019;6(6):2235-2241.
  • Patil J. Deodhar J, Wagh S Pandit AN. High risk factors for development of Retinopathy of Prematurity. Indian Pediatrics. 1997;34:1024-1027
  • Maheshwari R, Kumar H, Paul VK, Singh M, Deorari AK, Tiwari HK. Incidence and risk factors of retinopathy of prematurity in a tertiary care newborn unit in New Delhi. The National medical journal of India. 1996;9(5):211-214.
  • Selvakumar R, Vasanthamalar C, Jeyaramapandian V. Study on Retinopathy of Prematurity and Its Risk Factors in Preterm Babies and Birth Weight <2 kg Admitted in a Rural Medical College. Int J Sci Stud. 2018;5(12):96-99.